Ceres Nanosciences receives $6.5M NIH Award

The award money will help to expand Nanotrap Particle manufacturing capacity for COVID-19 testing

9 Sept 2020
Sophie Ball
Publishing / Media

Industry news

Ceres Nanosciences, has announced it has been awarded a contract from the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADxSM) initiative. The contract, for $6.5 million, will support an expansion to increase the manufacturing capacity of Ceres’ Nanotrap® Virus Particles for COVID-19 tests.

Ceres’ Nanotrap Virus Particles improve diagnostic testing for SARS-CoV-2 by eliminating the need for RNA extraction kits, reducing sample processing time, and improving the sensitivity of the downstream assays in point-of-care systems and in high-throughput laboratory-developed tests.

The RADx initiative was launched by NIH to speed innovation in the development, commercialization, and implementation of technologies for COVID-19 testing. One of the goals of the RADx initiative is to expand the national testing capacity to more than 6 million people per day. The key to increasing this capacity is addressing the reliance on supply-chain-limited RNA extraction kits. For example, in its April 2020 SARS-CoV-2 Diagnostic Testing Survey, the Association of Molecular Pathology reported that more than 80% of diagnostic testing laboratories had experienced supply chain shortages of testing reagents such as RNA extraction kits, causing delayed or decreased testing.

Ceres expects to increase its manufacturing capacity to be able to supply Nanotrap® particles for at least 2 million SARS-CoV-2 tests per week in early 2021. Since Nanotrap® Virus Particles also improve diagnostic testing for influenza virus and RSV, this scale-up will support multiplexed testing of respiratory viruses during this winter’s flu season.

“We are laser-focused on doing our part to increase the nation’s testing capacity,” said Ross Dunlap, Ceres Nanosciences CEO. “Knowing that we can do that, while simultaneously improving the quality of the tests being offered, motivates us each and every day.”

“With previous funding from DARPA and Schmidt Futures we proved that our technology improves detection of a wide range of respiratory viruses, including influenza viruses, coronaviruses, and respiratory syncytial virus,” said Ben Lepene, Ceres Nanosciences CTO. “This new support from the NIH is going to help us deliver it at scale.”

This project is supported by the NIH Rapid Acceleration of Diagnostics (RADxSM) program and has been funded in whole or in part with Federal funds from the National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Department of Health and Human Services, under Contract No. 75N92020C00021.

For more of the latest science news, straight to your inbox, become a member of SelectScience for free today>>

Links

Tags

DNA / RNA Extraction and PurificationPurified DNA and RNA are required for numerous downstream molecular biology applications. Consequently, the importance of high-quality DNA/RNA extraction and purification equipment cannot be underestimated. Many purification kits are available and are typically optimized for nucleic acid type and source, including plasmid DNA, genomic DNA, mRNA, RNA and viral nucleic acid purification kits. Automated extraction and purification of nucleic acids can be implemented with magnetic bead separator instruments or high-throughput purification workstations. Find the best DNA/RNA extraction and purification equipment in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.DNA / RNA QuantificationDetection and quantification of nucleic acids is important in molecular biology, cloning, expression, forensics and clinical diagnostics. Nucleic acids can be detected by labeling with colorimetric, fluorescent or radio labels and using in situ hybridization kits to identify specific sequences. Multiple nucleic acids can be detected and quantified at once using RNA / DNA detection beads or RNA / DNA microarrays. Find the best DNA / RNA Quantification products in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.VirusesViruses are microscopic pathogens that require a host cell to replicate. Understanding their structure, replication cycle, and impact on the immune system is crucial in developing effective treatments, vaccines, and diagnostic methods. Research continues to focus on emerging viral diseases and antiviral drug discovery. Explore solutions for virus research, detection, and treatment in our peer-reviewed product directory; compare products, check customer reviews, and get pricing directly from manufacturers.CoronavirusCoronaviruses are a large family of viruses that can cause illnesses ranging from the common cold to more severe diseases like COVID-19. Research into the biology, transmission, and treatment of coronaviruses has become a global priority, particularly since the emergence of SARS-CoV-2. Understanding the virus�s structure and behavior is essential for developing vaccines, diagnostics, and antiviral treatments. Explore our peer-reviewed product directory to discover the latest research tools, diagnostic tests, vaccines, and treatments for coronavirus, compare products, read reviews, and receive pricing directly from manufacturers.Covid-19COVID-19, caused by the SARS-CoV-2 virus, has led to a global health crisis with profound impacts on societies and economies. Research into diagnostics, vaccines, treatments, and understanding viral mechanisms continues to evolve. The pandemic has accelerated innovations in healthcare and biopharmaceuticals, including novel vaccine platforms and rapid testing technologies. Browse our peer-reviewed product directory to find top COVID-19 testing kits, research tools, vaccines, and treatments, compare products, read reviews, and receive direct pricing from manufacturers.
Ceres Nanosciences receives $6.5M NIH Award